Clinical trial
QLM2010 Comparative Pharmacokinetic Study With 2-Minute Intravenous Administration
NCT07817004 is registered in ClinicalTrials.gov with Qilu Pharmaceutical (Hainan) Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- QLM2010 Comparative Pharmacokinetic Study With 2-Minute Intravenous Administration
- Lead sponsor
- Qilu Pharmaceutical (Hainan) Co., Ltd.
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- December 31, 2026
- Enrollment
- 42 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
chemotherapy-induced nausea and vomiting (cinv)